Xeris Pharmaceuticals Reports Second Quarter 2021 Financial Results and Recent Highlights

Go back to Xeris Pharmaceuticals Reports Second Quarter 2021 Financial Results and Recent Highlights
(NASDAQ: XERS) Delayed: 6.92 -0.03 (0.43%)
Previous Close $6.95    52 Week High
Open $6.98    52 Week Low
Day High $7.11    P/E N/A 
Day Low $6.87    EPS
Volume 383,221